Cinacalcet does not affect the activity of cytochrome P450 3A enzymes, a metabolic pathway for common immunosuppressive agents : a randomized, open-label, crossover, single-centre study in healthy volunteers

Drugs in R&D
Desmond PadhiMaurice Emery

Abstract

Cinacalcet HCl (cinacalcet) is approved for the treatment of secondary hyperparathyroidism in subjects receiving dialysis and for the reduction of hypercalcaemia in patients with parathyroid carcinoma. The drug may also be co-administered with medications used in the renal transplantation setting, such as immunosuppressants. Cinacalcet, as well as some immunosuppressants such as ciclosporin, tacrolimus and sirolimus, is partially metabolized by the cytochrome P450 3A enzymes (CYP3A). This study aimed to evaluate the potential inhibitory effects of cinacalcet on CYP3A activity using midazolam as a probe substrate in healthy volunteers. In this randomized, open-label, crossover, two-treatment, two-period, single-centre study, 12 healthy volunteers received either oral cinacalcet 90 mg once daily for 5 days plus a single oral dose of midazolam 2 mg on day 5, or a single oral dose of midazolam 2 mg on day 1. Following a 10-day washout period, subjects received the alternate treatment. Blood samples were collected predose and at selected time points up to 24 hours after dosing with midazolam for measurement of midazolam pharmacokinetic parameters. Eleven subjects completed the study. Mean (standard deviation) midazolam maximum plasm...Continue Reading

References

Aug 22, 1991·The New England Journal of Medicine·B A JulianL D Quarles
Jun 1, 1997·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·M M Salem
Dec 9, 1998·Kidney International·P MessaG Mioni
Mar 7, 2001·Nature Medicine·M Eichelbaum, O Burk
Nov 17, 2001·American Journal of Hypertension·B SuwelackH Hohage
Jan 24, 2002·Journal of the American Society of Nephrology : JASN·Armando TorresEduardo Salido
Jan 25, 2003·Transplantation·Ted R MikulsKenneth G Saag
Jun 5, 2003·Clinical Transplantation·James HeafNiels Fogh-Andersen
Jun 20, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Thorir D BjornssonUNKNOWN FDA Center for Drug Evaluation and Research (CDER)
Nov 1, 2003·The Journal of Pharmacology and Experimental Therapeutics·Edward F NemethDavid Martin
Dec 11, 2003·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·Line M VautourJames T McCarthy
Apr 9, 2004·The New England Journal of Medicine·Geoffrey A BlockWilliam G Goodman
May 6, 2005·Clinical Pharmacokinetics·Desmond PadhiJohn T Sullivan
May 28, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Pieter EvenepoelYves Vanrenterghem
Jun 9, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Andreas L SerraRudolf P Wüthrich
Jun 9, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Anja E KruseMarkus G Mohaupt
Jul 6, 2005·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Wilfried GwinnerAnke Schwarz
Aug 9, 2005·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Domenico RubelloAngelo Carpi
Jul 28, 2006·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·N LecaO Pankewycz
Sep 29, 2006·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Andreas L SerraRudolf P Wüthrich
May 19, 2007·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Anja E KruseMarkus G Mohaupt
May 24, 2007·Clinical Pharmacokinetics·Robert Z HarrisDesmond Padhi
Aug 21, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Jeffrey SchiffMarcelo Cantarovich
Oct 25, 2007·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Pål FalckHallvard Holdaas

❮ Previous
Next ❯

Citations

Jan 1, 2012·Expert Review of Endocrinology & Metabolism·Filomena Cetani, Claudio Marcocci
May 2, 2015·Clinical Pharmacokinetics·Jacqueline A GibbonsTaoufik Ouatas
Aug 16, 2018·Frontiers in Medicine·Chandan VangalaVenkat Ramanathan
Sep 14, 2010·Transplantation Proceedings·J B CopleyS M Sprague

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.